On September 13, 2019, the U.S. Food and Drug Administration (FDA) issued a statement that it had learned Zantac and other ranitidine medications contained NDMA (N-nitrosodimethylamine). NDMA is a probable human carcinogen, meaning it can cause cancer.

At that time, the FDA was investigating whether the levels of NDMA in ranitidine posed any risk to patients. The FDA did not call for patients to stop taking Zantac or other ranitidine medications. However, since that time, the FDA has notified consumers and medical providers of numerous voluntary recalls of medications containing ranitidine.

If you or a loved one has taken Zantac or ranitidine and believe you may have suffered because of exposure to NDMA, contact the Zantac injury lawyers of Rosen Injury Lawyers for a free consultation.

What is Zantac?

Zantac (a common brand name for ranitidine) entered the market in 1981. The medication is a histamine-2 (HD) blocker. It was a common medication prescribed by physicians for the treatment of acid reflux, heartburn, and ulcers. A lower dose of Zantac became one of the most popular over-the-counter medications for heartburn and acid reflux.

Multiple manufacturers rushed to create generic versions of Zantac. Many prescription and over-the-counter versions of ranitidine were available.

In September 2019, Health Canada requested that companies stop distributing ranitidine products in Canada as it assessed the NDMA risk.

What is NDMA and Why Should I Be Worried?

Studies have shown that NDMA is a probable carcinogen for humans. It is an environmental contaminant that can be found in various food products and water. Exposure to high doses of ranitidine for long periods increases the risk of developing cancer.

FDA Continues Testing Ranitidine Medications for Cancer-Causing

According to the FDA, consuming small doses of ranitidine per day is considered “reasonably” safe for humans. The reasonably safe daily intake limit of NDMA is between 0.096 micrograms (.032 parts per million). The FDA published the results of its ranitidine tests on November 1, 2019. Some of the tests revealed levels of NDMA that exceed the reasonably safe daily intake limit.

The FDA asked companies to voluntarily recall ranitidine that contained levels of NDMA that exceed the maximum daily intake level. It also requested manufacturers to continue to conduct laboratory testing to determine the levels of NDMA in their products.

The FDA continues to investigate the matter and issues notices and advisories regarding Zantac and ranitidine. The FDA states that it will take appropriate measures when necessary to protect the public.

Doctors, patients, and consumers are urged to report any adverse ranitidine reactions to the FDA through its MedWatch program.

Zantac Lawsuits Filed Throughout the United States

Ranitidine and Zantac lawsuits have been filed claiming damages from NDMA exposure. NDMA is hazardous for humans and can cause a variety of conditions.

Symptoms and conditions associated with NDMA exposure include, but may not be limited to:

Plaintiffs in the Zantac lawsuits have accused the manufacturers of Zantac and generic ranitidine of negligence and other wrongdoing by allowing consumers to be exposed to unsafe levels of N-nitrosodimethylamine. They claim that the companies knew or should have known about the ranitidine contamination, but failed to take any steps to warn consumers or protect consumers.

Recovering Compensation for Zantac Cancer Claims

If you took Zantac or ranitidine and have been diagnosed with cancer, you may have a claim against the manufacturer of Zantac or a generic form of ranitidine. Also, if you develop any of the complications associated with ranitidine or Zantac, you might be entitled to compensation for damages and losses.

Examples of damages that might be compensable in a Zantac lawsuit include, but are not limited to:

A Zantac lawsuit can help individuals who have suffered harm after taking Zantac or ranitidine recover compensation for their financial losses and damages, as well as the suffering and pain endured because of the wrongdoing by the manufacturers and other parties.

Do Not Wait to File a Zantac or Ranitidine Claim

There are different deadlines for filing claims related to Zantac or ranitidine cancer and complications. One or more state and federal statutes of limitations may apply in your case. It is best to contact a Zantac lawsuit attorney as soon as you suspect that you might have been negatively impacted after taking ranitidine or Zantac.

Contact our Zantac lawsuit attorney immediately for a free consultation to discuss your case.

How Can Rosen Injury Lawyers Help Me?

Rosen Injury Lawyers is committed to helping individuals harmed by ranitidine or Zantac. Our dangerous drug attorneys and defective drug attorneys work diligently to ensure that we have the latest information related to FDA recalls and FDA tests.

Determining who is responsible for the NDMA contamination can be a complex undertaking. For this reason, it is vital that you work with experienced, skilled, and knowledgeable pharmaceutical litigation attorneys.

We work with various medical experts and industry experts to gather evidence related to NDMA exposure and how NDMA can cause cancer and other conditions. Our law firm has the resources necessary to handle large, complex drug-related litigation cases.

Our pharmaceutical litigation lawyers carefully assess each case individually. We explain the Zantac lawsuit process and potential settlement of Zantac claims to you so that you feel comfortable with your decision to proceed with a Zantac injury claim.

Taking on a big pharmaceutical company can be intimidating. However, our legal team is with you during each step of the process to provide support and guidance.

Benefits of Filing a Zantac – Ranitidine Lawsuit

There are numerous benefits of filing a lawsuit for the harmful effects caused by ranitidine or Zantac. Some of the benefits of filing a personal injury lawsuit when you are injured because of a defective drug or dangerous drug include:

When you file a Zantac claim or Zantac lawsuit, you do not pay upfront attorneys’ fees. Attorneys’ fees are collected from any settlement of your claim or the Zantac lawsuit. In some cases, a court may order the defendants to pay your attorneys’ fees, court costs, and expenses related to the litigation.

What Should You Do If You Are Taking or Have Taken Zantac?

If you have taken Zantac or ranitidine, the FDA does not recommend that you stop taking the medication. Instead, you should contact your physician immediately.

Your physician can discuss the potential risks of taking ranitidine, including any alternatives to Zantac. Some alternatives to Zantac that you might want to discuss with your doctor include Nexium, Pepcid, Prilosec, Tagamet, and Prevacid. You may also want to discuss non-pharmaceutical to treat heartburn, acid reflux, and ulcers.

Your doctor can also address your concerns regarding health issues, including any symptoms that you might be experiencing that could indicate you have been injured by Zantac.

Call For Help With Your Zantac Injury Lawsuit

Call Rosen Injury Lawyers for a free consultation with a Zantac personal injury attorney. We handle claims involving Zantac and ranitidine related cancers and injuries. Our lawyers also handle cases involving wrongful deaths caused by NDMA exposure.

Call us to speak about your options with a compassionate legal professional. We are here to help you when you have questions or concerns about Zantac and ranitidine. We provide free case evaluations to help you determine if you are eligible to join a class-action lawsuit or file an individual Zantac lawsuit. Help us hold the manufacturers and drug companies responsible for the harm they have inflicted on your and many other individuals.